Bürdek, M.; Prinz, P.U.; Mutze, K.; Bosch, M.; Tippmer, S.; Coluccio, A.; Geiger, C.; Majumder, S.; Longinotti, G.; Schendel, D.J.
Preclinical Development of Costimulatory Switch Protein (CSP)-Armored NY-ESO-1/LAGE-1a-Specific TCR-T Cells for Therapy of Hard-to-Treat PD-L1-Positive Solid Tumors. Int. J. Transl. Med. 2025, 5, 45.
https://doi.org/10.3390/ijtm5040045
AMA Style
Bürdek M, Prinz PU, Mutze K, Bosch M, Tippmer S, Coluccio A, Geiger C, Majumder S, Longinotti G, Schendel DJ.
Preclinical Development of Costimulatory Switch Protein (CSP)-Armored NY-ESO-1/LAGE-1a-Specific TCR-T Cells for Therapy of Hard-to-Treat PD-L1-Positive Solid Tumors. International Journal of Translational Medicine. 2025; 5(4):45.
https://doi.org/10.3390/ijtm5040045
Chicago/Turabian Style
Bürdek, Maja, Petra U. Prinz, Kathrin Mutze, Miriam Bosch, Stefanie Tippmer, Andrea Coluccio, Christiane Geiger, Snigdha Majumder, Giulia Longinotti, and Dolores J. Schendel.
2025. "Preclinical Development of Costimulatory Switch Protein (CSP)-Armored NY-ESO-1/LAGE-1a-Specific TCR-T Cells for Therapy of Hard-to-Treat PD-L1-Positive Solid Tumors" International Journal of Translational Medicine 5, no. 4: 45.
https://doi.org/10.3390/ijtm5040045
APA Style
Bürdek, M., Prinz, P. U., Mutze, K., Bosch, M., Tippmer, S., Coluccio, A., Geiger, C., Majumder, S., Longinotti, G., & Schendel, D. J.
(2025). Preclinical Development of Costimulatory Switch Protein (CSP)-Armored NY-ESO-1/LAGE-1a-Specific TCR-T Cells for Therapy of Hard-to-Treat PD-L1-Positive Solid Tumors. International Journal of Translational Medicine, 5(4), 45.
https://doi.org/10.3390/ijtm5040045
